Tag - pharmaceuticals

 
Menu
Search
 
January 31, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Takeda Pharmaceutical's headquarters in Tokyo
BUSINESS / Companies
Jan 30, 2025
Takeda picks first female CEO of centuries-old drugmaker
Julie Kim, 54, has been running Takeda’s U.S. operations since 2022 and will assume the role of CEO in June next year, subject to shareholder approval, the company said.
Kobayashi Pharmaceutical executives bow their heads at a news conference in Osaka in March following a health hazard scandal involving the firm's supplements containing red fermented rice.
JAPAN / Crime & Legal
Jan 29, 2025
Hong Kong fund to sue former Kobayashi Pharma execs
The fund will seek a total of roughly ¥11 billion in damages from former Chairman Kazumasa Kobayashi and six then-board directors.
In 2024, child mortality for children before the age of 5 reached a record low of 3.6%, down from over 25% in 1950. For most of history, about half of all newborns died as children.
COMMENTARY / World
Jan 22, 2025
Even this year is the best time ever to be alive
Another way of looking at it: Every day over the past couple of years, roughly 30,000 people moved out of extreme poverty worldwide.
The U.S. Food and Drug Administration's approval of novel breast cancer treatment by Daiichi Sankyo and AstraZeneca led Daiichi Sankyo's shares to post the largest intraday gain since August on Monday.
BUSINESS / Companies
Jan 20, 2025
Daiichi Sankyo rises most in five months on cancer drug approval
Datroway, developed with AstraZeneca, has been approved for patients with advanced breast tumors.
Daiichi Sankyo's headquarters in Tokyo
BUSINESS
Jan 18, 2025
AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug
The Food and Drug Administration approved the drug for patients with advanced breast tumors whose cells bear a certain genetic signature.
A research team from Nagoya University and other institutions hopes that further testing on humans involving the antioxidant luteolin will lead to the development of a drug for preventing or reducing gray hair.
JAPAN / Science & Health
Jan 14, 2025
Antioxidant found in broccoli, celery suppresses gray hair in mice
Researchers hope that further testing on humans could lead to the development of a drug that would prevent or reduce gray hair.
Cancer patient Anne Maldzinski was given an experimental therapy developed by French biotech MaaT Pharma through an early access program. The effect was dramatic.
WORLD / Science & Health
Jan 9, 2025
Drug from bowel bacteria helps blood cancer patients facing deadly complication
A burgeoning field of therapies is harnessing the power of the microbiome to treat and potentially prevent diseases.
While many patients showed improvement in Fanconi syndrome, 87% still had kidney function indicators below standard levels despite two months having passed since Kobayashi Pharmaceutical urged consumers to stop taking the supplement.
JAPAN / Science & Health
Jan 8, 2025
Tainted beni kōji supplement linked to persistent kidney damage, study finds
The Osaka University study analyzed data from patients who reported health issues between late March and late April 2024.
Five years since COVID-19 started upending the world, the virus is still infecting and killing people across the globe — though at far lower levels than during the height of the pandemic.
WORLD / Science & Health
Jan 8, 2025
Is the world ready for the next pandemic?
While the U.N. health agency considers the world more prepared than it was when Covid hit, it warns we are still not nearly ready enough.
A woman receives a COVID-19 vaccine in Minato Ward, Tokyo, in October.
JAPAN / Science & Health
Dec 29, 2024
Meiji Seika Pharma files suit against lawmaker over 'unfounded' vaccine claims
CDP Lower House lawmaker Kazuhiro Haraguchi has said that the drugmaker's replicon vaccine is "akin to a biological weapon."
The health ministry aims to improve accessibility, particularly in areas with few pharmacies.
JAPAN / Science & Health
Dec 27, 2024
Japan to allow convenience stores to handle over-the-counter drugs
Under current regulations, OTC drugs can only be sold at stores with pharmacists or other qualified personnel stationed at all times.
Kobayashi Pharmaceutical's Osaka factory
BUSINESS / Companies
Dec 26, 2024
Hong Kong fund increases its stake in Kobayashi Pharmaceutical
Oasis Management said its stake in Kobayashi Pharmaceutical climbed to 10.1% from 7.5%.
Official prices of nearly half of drugs in Japan will be reduced to lower the burden on patients.
JAPAN
Dec 25, 2024
Japan ministers agree on price cuts for half of all drugs
Ministers also agreed to raise the upper limit on out-of-pocket medical expenses.
The government plans to lower official drug prices for fiscal 2025 while carefully considering the scope of items subject to the planned cuts in light of the impacts on drugmakers.
BUSINESS
Dec 4, 2024
Japanese drug market prices 5.2% lower than official prices
Generic drugs made up 62.1% of the market by value in September, with a government target of 65% by fiscal 2029 to cut medical costs.
Out of over 16,000 pharmaceutical products, 3,103 — or 18.5% — were either in limited or suspended supply as of the end of October, according to a recent survey. Of these, over 60% are generic drugs.
JAPAN
Nov 21, 2024
Japan's generic drug shortage continues as flu season kicks off
The supply shortfall is due to a string of scandals that hit the generic drug industry in recent years as well as other structural problems.
A Nigerian health official administers an mpox vaccination at Federal Medical Center in Abuja, Nigeria, on Monday.
JAPAN
Nov 20, 2024
WHO approves Japanese pharmaceutical company's mpox vaccine
The listing from the World Health Organization paves the way for countries worldwide to quickly approve and import the vaccine for distribution.
Lecanemab was developed by drugmakers Eisai of Japan and Biogen of the United States.
JAPAN / Science & Health
Nov 15, 2024
European agency switches to recommending new Alzheimer's drug
The committee judged that the efficacy of lecanemab outweighs the risk for some patients.
For patients using donanemab, it will cost them about ¥3.08 million per year. But national insurance coverage will have the government shoulder most of the cost.
JAPAN / Science & Health
Nov 13, 2024
Japan OKs insurance coverage of Alzheimer's drug donanemab
Donanemab became the second Alzheimer's drug that targets causative deposited plaque in the brain to win the coverage after lecanemab.
A pharmacist displays boxes of Ozempic in Provo, Utah.
BUSINESS
Nov 6, 2024
Obesity drug maker Novo Nordisk posts strong profit
Europe's most valuable company and the main driver of the Danish economy said it expected its 2024 full-year sales to be up by 23% to 27% from a year earlier.
Since October, patients have been asked to pay more for brand-name drugs prescribed by medical institutions if the patents have expired.
JAPAN
Nov 6, 2024
Japan raises out-of-pocket costs for off-patent drugs
With the increases, the government aims to reduce health care costs by encouraging greater use of generic drugs.
Japan begins feeling the pain of BOJ rate hikes more concretely
People were more concerned about the direct and specific impact of the Bank of Japan's latest rate hike on their personal lives, according to an artificial intelligence-driven analysis of various platforms, including social media.
Sumo’s newest yokozuna is all smiles — but major challenges await
Hoshoryu (front, second from left) celebrates after being promoted to yokozuna on Wednesday in Tokyo.
Japanese man ends his 6,000 kilometer Africa rickshaw trek in Cape Town
Yuji "Gump" Suzuki, the Japanese runner and social media sensation, runs with supporters while pushing his rickshaw as he nears his goal in Cape Town, South Africa, on Sunday.
No survivors from jet and helicopter collision in Washington, officials say
Part of the wreckage is seen as rescue crews search the waters of the Potomac River Thursday morning after a passenger plane on approach to Reagan National Airport crashed into the river after colliding with a U.S. Army helicopter, near Washington, D.C., on Wednesday evening.
Cherry blossom season predicted to begin in Tokyo on March 21
Tokyo is expected to lead the season with its first cherry blossoms on March 21, followed by Fukuoka, Kochi and Hiroshima prefectures as well as the city of Yokohama on March 22.
For two weeks only, cold-water yellowtail can give you chills
Yellowtail caught during the coldest period of the year is delicious enough — but paired with a classic method of marinade and pan-searing, it's divine.
In meat- and fish-loving Japan, veganism is making a comeback
Though vegan restaurants have been on the upswing since 2017, Japanese vegans still lack a wide variety of options.
Who are the key figures involved in the growing Fuji TV scandal?
Fuji TV adviser Hisashi Hieda in 2005
What we learned at Fuji TV's marathon Nakai scandal news conference
Members of the media raise their hands for questions as outgoing Fuji TV President Koichi Minato attends a news conference in Tokyo on Monday.
Kanoa Igarashi dreams big as surfing championship tour gets underway
Kanoa Igarashi surfs in the Hurley Pro Sunset Beach competition in Oahu, Hawaii, on Feb. 18.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Ayumi Matsuki, a priestess at Yoshiwara Shrine, shows off some "o-mamori" charms. She says visitors to the shrine have increased since the NHK drama “Unbound” began airing this month.
Tracing Tsutaya Juzaburo, Edo’s media maverick
By Alex K.T. Martin

SUSTAINABLE JAPAN

mission sustainability vol.14 : Unicharm Corp.Unicharm recycles diapers back into diapers
mission sustainability vol.14 : Unicharm Corp.Unicharm recycles diapers back into diapers

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER